Skip to main content
Equibles

RENAISSANCE TECHNOLOGIES LLC

Position in LFCR — Lifecore Biomedical, Inc. De

CIK 1037389 NEW YORK, NY
Back to LFCR Full portfolio

Position in LFCR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$550,509
+$494,079 QoQ
Shares Held
104,859
+853.3% QoQ
Ownership
0.277%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 98 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LFCR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $2,242,873,379 across 49 Drug Manufacturers - Specialty & Generic names. LFCR ranks #37 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 UTHR
UNITED THERAPEUTICS Corp
 1,708,739 $925,846,052
2 NBIX
Neurocrine Biosciences Inc
 2,335,897 $393,692,080
3 ALKS
Alkermes plc.
 6,460,928 $338,552,627
4 RDY
Dr Reddys Laboratories Ltd
 7,347,028 $106,458,435
5 ZTS
Zoetis Inc.
 1,403,300 $100,841,138
6 SUPN
Supernus Pharmaceuticals, Inc.
 1,478,180 $68,750,151
7 COLL
Collegium Pharmaceutical, Inc
 1,366,549 $49,469,073
8 PCRX
Pacira BioSciences, Inc.
 1,733,801 $43,986,531

All Filings in LFCR

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $550,509 104,859
2024-06-30 $56,430 11,000
2023-12-31 $227,173 36,700
2023-09-30 $523,215 69,300
2023-06-30 $1,056,457 109,251
2023-03-31 $648,084 171,451
2022-12-31 $746,178 115,151
2022-09-30 $1,057,021 118,900
2022-06-30 $1,264,196 126,800
2022-03-31 $1,365,282 117,900
2021-12-31 $1,295,370 116,700
2021-09-30 $1,114,698 120,900
2021-06-30 $2,257,323 200,651
2021-03-31 $3,165,700 298,651
2020-12-31 $2,213,389 203,999
2020-09-30 $1,081,836 111,300
2020-06-30 $804,756 101,100
2020-03-31 $159,027 18,300